Clinical improvement and positive changes in the ultrasound and uroflowmetry
parameters in patients with CP/CPPS who used DATD could be explained by positive changes in the prostate at the capillary level.
was defined as the presence of peak urine flow less than 20 mL/sec measured by an uroflowmeter.
, Position-related change, Healthy young men.
, which is less invasive and easy to perform, was used for follow-up of the patient.
In a further analysis of the uroflowmetry
data, Heyns et al.
Table 3 Values of uroflowmetry
in placebo and Se-SM groups.
prostate volume, mean voided urine volume and free uroflowmetry
(Qmax), as part of noninvasive urodynamic studies.
is the essential diagnostic test in dysfunctional voiding, and a staccato urine flow pattern is the mainstay of diagnosis.
MMS has been producing urodynamic systems for more than 20 years, including Alpha(TM), Solar(TM), Solar Blue(TM) Urodynamics Systems and Flowmaster(TM) and Flowstar(TM) Uroflowmetry
Follow up The follow up consisted of a history and level of satisfaction of the patient and protection if any used post operatively, clinical examination of vaginal and skin wound, uroflowmetry
and USG for the residual urinary volume.
Using repeated measures of symptom score, uroflowmetry
and prostate specific antigen in the clinical management of prostate disease.
Assessments included prostate volume (PV) by transrectal ultrasound (TRUS), maximum flow rate (Qmax) on uroflowmetry
, post-void residual urine volume (PVR), International Prostate Symptom Score (IPSS), prostate specific antigen (PSA) levels, serum chemistry, and adverse events.